Steven D. Wood - May 17, 2024 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ David M. Urso, as attorney in fact
Stock symbol
MEIP
Transactions as of
May 17, 2024
Transactions value $
$9,827
Form type
4
Date filed
5/21/2024, 04:00 PM
Previous filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEIP Common Stock Award $9.83K +3.1K +246.23% $3.17 4.36K May 17, 2024 Direct F1
holding MEIP Common Stock 67.7K May 17, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted-average price. These shares were purchaased in multiple transactions with prices ranging from $3.10 to $3.18 per share. The reporting person undertakes to provide MEI Pharma, Inc., any security holders of MEI Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set in this Form 4.
F2 The reported shares are held of record by GreenWood Builders Fund III, LP. Mr. Steven Wood is the Chief Investment Officer at GreenWood Investors LLC, who severs as investment advisor to GreenWood Builders Fund III, LP., and as such may be deemed to beneficially own the securities held by GreenWood Builders Fund III, LP. Mr Wood disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.